Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

Asthma Management: New Developments


This CE activity was originally published in The Rx Consultant.  If you received credit for it previously, you cannot receive credit for it again.

Asthma is a chronic inflammatory disease that affects over 339 million individuals worldwide. Characterized by variable airflow limitation and bronchial hyperresponsiveness, symptoms include wheezing, shortness of breath, chest tightness, and/or cough. Asthma symptoms are episodic in nature, often worse at night or in the early morning, and can be triggered by factors such as exercise, airborne allergens, pollution, cigarette smoking, weather changes (eg, very cold, low humidity), and viral upper respiratory infections. To diagnose asthma, patients must have a history of variable respiratory symptoms, as well as limited expiratory airflow that has been confirmed with spirometry.

The long-term goals of asthma management are to achieve good symptom control that enables patients to maintain normal activity levels, to minimize persistent airflow limitation, side effects from treatment, and asthma-related exacerbations, and to prevent asthma-related death...

Format
This CE activity is a monograph (PDF file).

Fee

$10.00

CE Hours

1.50

CE Units

0.150

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists, Nurse Practitioners, Clinical Nurse Specialists, and Registered Nurses
  • Pharmacists
  • Nurse Practitioners

Accreditation(s)

This CE activity was developed by The Rx Consultant, a publication of Continuing Education Network, Inc.

CE activities for Pharmacists and Pharmacy Technicians:
This continuing education (CE) activity meets the requirements of all state boards of pharmacy for approved continuing education hours.  CE credit is automatically reported to CPE Monitor.
 
CE activities for Nurse Practitioners and Clinical Nurse Specialists: 
    This continuing education activity meets the requirements of:
        The American Nurses Credentialing Center (ANCC) for formally approved continuing education (CE) hours, and CE hours of pharmacotherapeutics.
        The American Academy of Nurse Practitioners Certification Program (AANPCP) for acceptable, accredited CE.
 
    This is a pharmacotherapeutics/pharmacology CE activity.
  • The ANCC requires all advanced practice nursing certificants (CNSs and NPs) to complete 25 CE hours of pharmacotherapeutics as a portion of the required 75 continuing education hours.
  • Pharmacology CE is recommended by the AANPCP and will be required for Certificants renewing certification starting January 2017.  
  • Most State Boards of Nursing require a minimum number of pharmacy contact hours to renew an advanced practice license.
 
 
Accreditation Council for Pharmacy Education
Continuing Education Network, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Requirements for CE Credit

To receive CE credit, the participant must read the monograph in its entirety, complete the online post-test and receive a score of 70% or greater, and complete the online evaluation.
 
Pharmacists and Pharmacy Technicians -
 
Be sure your profile has been updated with your NAPB e-profile # and birth date information BEFORE completing the online evaluation, or your credits cannot be reported to CPE Monitor.
 
Continuing pharmacy education credit is automatically reported to CPE Monitor once the post-test & evaluation are successfully completed.

 

 

 

Objectives

  • Discuss the current GINA recommendations for stepwise treatment of asthma, including the role for SABA, LABA, and inhaled corticosteroids (ICS). Recognize ICS-LABA combination products approved for the treatment of asthma and their age-specific daily doses.
  • Discuss the reasons and possible solutions for poor asthma medication adherence. Provide 2 examples of personalized controller therapy that may not be consistent with general treatment recommendations in clinical practice guidelines.
  • Describe the rationale for the use of biologics in patients with severe asthma uncontrolled by ICS and bronchodilator therapy. List approved agents, dosing, and potentially serious side effects.

Speaker(s)/Author(s)

Jessica Wallace, PharmD
Assistant Professor, Lipscomb University College of Pharmacy and Health


Brief Bio : Jessica Wallace, PharmD, BCPS is an Assistant Professor of Pharmacy Practice at Lipscomb University College of Pharmacy and Health Sciences in Nashville, TN. She maintains a practice site precepting students and residents on the Internal Medicine Service at the Veterans Affairs Tennessee Valley Healthcare System, Nashville.

Jonathan Hughes, PharmD, BCPS, BCACP
Ambulatory Care Clinical Pharmacist Specialist, Saint Louise Family Medicine Center in Murfreesbor


Brief Bio : Jonathan Hughes, PharmD, BCPS, BCACP is an Ambulatory Care Clinical Pharmacist Specialist at the Saint Louise Family Medicine Center in Murfreesboro, TN. He is also an Assistant Professor for the University of Tennessee Health Science Center, holding joint appointments with the Department of Clinical Pharmacy, College of Pharmacy, and the Department of Clinical Medical Education, College of Medicine.

Activity Number

0428-0000-20-002-H01-P

Release Date: Feb 24, 2020
Credit Expiration Date: Feb 24, 2023

CE Hours

1.50

Fee

$10.00
 

The CE Activity developed by The Rx Consultant